LUCD - NASDAQ

Lucid Diagnostics Inc.

Lucid Diagnostics Inc.

LUCDยทNASDAQ

$1.00

-0.99%
HealthcareMedical - Devices

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$102.82M
EPS-0.6900
P/E Ratio-1.46
Earnings Date08/12/2026
Lucid Diagnostics Inc.

Lucid Diagnostics Inc. Fair Value Envelope

LUCD ยท NASDAQ

Our analysis suggests that LUCD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.005, this represents a potential HIDDEN relative to our calculated worth for Lucid Diagnostics Inc..

HIDDEN
Intrinsic Value
Current Price: $1.005

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value-$40.1B
+ Cash & Equivalents$34.7B
Firm Value-$5.4B
- Debt$25.8B
Equity Value-$31.2B
/ Shares Outstanding101,893,255B
DCF Value-$306
OVERVALUED BY 30539%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
-$23.2B
-$11.6B
-$5.8B
-$2.9B
-$1.5B
-$726.3M
-$363.2M
-$181.6M
-$90.8M
-$45.4M
Maintenance CapEx
-$19.7K
-$9.9K
-$4.9K
-$2.5K
-$1.2K
-$616
-$308
-$154
-$77
-$38
Owner Earnings
-$23.2B
-$11.6B
-$5.8B
-$2.9B
-$1.5B
-$726.3M
-$363.2M
-$181.6M
-$90.8M
-$45.4M
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
-$21.5B
-$10.0B
-$4.6B
-$2.1B
-$988.7M
-$457.7M
-$211.9M
-$98.1M
-$45.4M
-$21.0M
Terminal Value represents 0.0% of Enterprise Value
Negative Owner Earnings
This company generates negative free cash flow. Consider adjusting maintenance CapEx percentage or check the financial data.

Related Guides

Blog Categories

Continue your LUCD research with focused valuation guides.

DCF Modeling

Improve assumptions for intrinsic value accuracy.

Forecasting

Calibrate growth paths and terminal value behavior.

WACC

Refine discount-rate logic for valuation quality.

Cost of Capital

Match risk profile to expected return assumptions.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.